Juno Therapeutics and investors reach settlement related to fatal drug trial

The $24 million mediated settlement stems from a string of patient deaths that nearly derailed Seattle’s star biotech startup two years ago.

The rest is here:
Juno Therapeutics and investors reach settlement related to fatal drug trial